- Home
- ARDX vs CRMD Comparison
ARDX vs CRMD Comparison
Compare ARDX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CRMD
- Stock Information
- Founded
- ARDX 2007
- CRMD 2006
- Country
- ARDX United States
- CRMD United States
- Employees
- ARDX N/A
- CRMD N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ARDX Health Care
- CRMD Health Care
- Exchange
- ARDX Nasdaq
- CRMD Nasdaq
- Market Cap
- ARDX 882.9M
- CRMD 925.6M
- IPO Year
- ARDX 2014
- CRMD 2010
- Fundamental
- Price
- ARDX $6.55
- CRMD $12.37
- Analyst Decision
- ARDX Strong Buy
- CRMD Strong Buy
- Analyst Count
- ARDX 9
- CRMD 8
- Target Price
- ARDX $10.50
- CRMD $17.57
- AVG Volume (30 Days)
- ARDX 3.2M
- CRMD 4.5M
- Earning Date
- ARDX 10-30-2025
- CRMD 10-29-2025
- Dividend Yield
- ARDX N/A
- CRMD N/A
- EPS Growth
- ARDX N/A
- CRMD N/A
- EPS
- ARDX N/A
- CRMD 0.79
- Revenue
- ARDX $386,146,000.00
- CRMD $121,484,498.00
- Revenue This Year
- ARDX $17.79
- CRMD $404.81
- Revenue Next Year
- ARDX $27.82
- CRMD $56.11
- P/E Ratio
- ARDX N/A
- CRMD $15.97
- Revenue Growth
- ARDX 83.88
- CRMD 14970.29
- 52 Week Low
- ARDX $3.21
- CRMD $5.60
- 52 Week High
- ARDX $7.18
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- ARDX 71.64
- CRMD 43.74
- Support Level
- ARDX $6.47
- CRMD $12.73
- Resistance Level
- ARDX $6.78
- CRMD $13.83
- Average True Range (ATR)
- ARDX 0.19
- CRMD 0.75
- MACD
- ARDX -0.05
- CRMD -0.18
- Stochastic Oscillator
- ARDX 67.18
- CRMD 22.78
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.